☰ Navigation Tabs
Vaccine elicited Antibody MU89 bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer
Starting Model(s) Initial Refinement Model(s) Type Source Accession Code Details experimental model PDB 6UM6
Refinement RMS Deviations Key Refinement Restraint Deviation f_dihedral_angle_d 13.142 f_angle_d 0.756 f_chiral_restr 0.053 f_bond_d 0.005 f_plane_restr 0.005
Sample V3-glycan vaccine induced antibody MU89 in complex with CH848.3.D0949.10.17chim.6R.DS.SOSIP.664_N133D_N138T HIV Env trimer
Specimen Preparation Sample Aggregation State PARTICLE Vitrification Instrument LEICA EM GP Cryogen Name ETHANE Sample Vitrification Details
3D Reconstruction Reconstruction Method SINGLE PARTICLE Number of Particles 72478 Reported Resolution (Å) 3.57 Resolution Method FSC 0.143 CUT-OFF Other Details Refinement Type Symmetry Type POINT
Map-Model Fitting and Refinement Id 1 (6UM6) Refinement Space REAL Refinement Protocol FLEXIBLE FIT Refinement Target Overall B Value Fitting Procedure Details
Data Acquisition Detector Type GATAN K3 (6k x 4k) Electron Dose (electrons/Å**2) 58.9
Imaging Experiment 1 Date of Experiment Temperature (Kelvin) Microscope Model FEI TITAN KRIOS Minimum Defocus (nm) 700 Maximum Defocus (nm) 2500 Minimum Tilt Angle (degrees) Maximum Tilt Angle (degrees) Nominal CS 2.7 Imaging Mode BRIGHT FIELD Specimen Holder Model Nominal Magnification Calibrated Magnification Source FIELD EMISSION GUN Acceleration Voltage (kV) 300 Imaging Details
EM Software Task Software Package Version PARTICLE SELECTION cryoSPARC IMAGE ACQUISITION Latitude CTF CORRECTION cryoSPARC 3.2 MODEL FITTING UCSF ChimeraX INITIAL EULER ASSIGNMENT cryoSPARC 3.2 FINAL EULER ASSIGNMENT cryoSPARC 3.2 CLASSIFICATION cryoSPARC 3.2 RECONSTRUCTION cryoSPARC 3.2 MODEL REFINEMENT PHENIX MODEL REFINEMENT Coot MODEL REFINEMENT ISOLDE
Image Processing CTF Correction Type CTF Correction Details Number of Particles Selected Particle Selection Details NONE 990218